ResultsIQ

ResultsIQ › Latest results › Galaxy Surfactants Limited

Galaxy Surfactants Limited Q1 FY27 results deck summary

NSE: GALAXYSURF · BSE: 540935

Results deck of 13 Aug 2026, summarised by AI from the filing.

Q1FY27 total revenue ₹1,785.2 cr (+38.5% YoY) and EBITDA ₹252.5 cr (+86.9% YoY), with India returning to double-digit volume growth.

Key takeaways

  1. EBITDA recovery EBITDA grew 87% YoY to ₹252 cr, with EBITDA/MT improving to ₹35,458/MT.
  2. India volumes India returned to double-digit volume growth after nearly two years, outpacing market growth.
  3. Raw material risk Raw material markets remained volatile, with elevated fatty alcohol prices and higher petrochemical feedstock costs.

Original filing on BSE

Galaxy Surfactants Limited Q1 FY27 results

As filed: Revenue ₹1,782 cr (+39% year on year), EBITDA ₹249 cr (+101% year on year), PAT ₹166 cr (+110% year on year), EBITDA margin 14.0% (+428 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹1,315 cr (+15% year on year), EBITDA ₹122 cr (−3% year on year), PAT ₹62.4 cr (−18% year on year), EBITDA margin 9.3% (−175 bps). Score 40 of 100, Below trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was well below it. EBITDA margin fell 175 bps year on year. Share price after the results: −7.9% in 29 days (Nifty 500: −0.1%).
  • Q3 FY26: Revenue ₹1,329 cr (+28% year on year), EBITDA ₹119 cr (+13% year on year), PAT ₹59.0 cr (+10% year on year), EBITDA margin 9.0% (−120 bps). Score 74 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA and profit before exceptional items growth were above it. EBITDA margin fell 120 bps year on year. Revenue rose ₹287 cr on a year ago, more than the ₹102 cr it added the year before. Share price after the results: −2.1% in 28 days (Nifty 500: −8.2%).
  • Q2 FY26: Revenue ₹1,326 cr (+25% year on year), EBITDA ₹110 cr (−13% year on year), PAT ₹66.0 cr (−22% year on year), EBITDA margin 8.3% (−365 bps). Score 41 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was below it; profit growth was well below it. EBITDA margin fell 365 bps year on year. Profit fell 16% from last quarter. Share price after the results: −11.5% in 30 days (Nifty 500: −0.5%).
  • Q1 FY26: Revenue ₹1,278 cr (+31% year on year), EBITDA ₹124 cr (−1% year on year), PAT ₹79.0 cr (−1% year on year), EBITDA margin 9.7% (−313 bps). Score 64 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin fell 313 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +2.0% in 30 days (Nifty 500: +2.2%).
  • Q4 FY25: Revenue ₹1,145 cr (+23% year on year), EBITDA ₹126 cr (+25% year on year), PAT ₹76.0 cr (−3% year on year), EBITDA margin 11.0% (+13 bps). Score 85 of 100, Above trend. Revenue and EBITDA growth were well above the company's own trend; profit growth was in line with it. EBITDA margin rose 13 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +5.6% in 28 days (Nifty 500: +0.2%).
  • Q3 FY25: Revenue ₹1,042 cr (+11% year on year), EBITDA ₹106 cr (−6% year on year), PAT ₹65.0 cr (−8% year on year), EBITDA margin 10.2% (−185 bps). Score 54 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 185 bps year on year. Profit fell 24% from last quarter.
  • Q2 FY25: Revenue ₹1,063 cr (+8% year on year), EBITDA ₹127 cr (+2% year on year), PAT ₹85.0 cr (+10% year on year), EBITDA margin 12.0% (−77 bps). Score 41 of 100, In line with trend. EBITDA margin fell 77 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Galaxy Surfactants Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.